Pulmonary Fibrosis…
it takes your breath away…
A Texas Non-Profit Organization
Pilot Study of Losartan Potassium in Patients With Idiopathic Pulmonary Fibrosis
POSTED: Tuesday, October 18, 2011
Objectvies
Evaluate the effects of losartan potassium on disease progression in patients with idiopathic pulmonary fibrosis.
Determine the safety of this drug in these patients.
- Find out more Genetic Discovery Published in New England Journal of Medicine, Co-Author Joins the Pulmonary Fibrosis Foundation Staff
POSTED: Sunday, May 1, 2011
CHICAGO, April 20, 2011 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) has appointed respiratory therapist
and certified clinical research coordinator, Dolly Kervitsky, RCP, CCRC, as Vice President of Patient Relations. Ms.
Kervitsky leaves leadership positions at National Jewish Health (NJH) where she served as the Program Manager for the
Interstitial and Autoimmune Lung Disease Program and founded the Genetic Counseling Program for Familial Pulmonary
Fibrosis.
"Dolly Kervitsky is a well-known leader and investigator in the world of interstitial lung disease and has worked with
the Foundation since 2009 when she joined our Medical Advisory Board," said Daniel M. Rose, MD, President and CEO. "We
are thrilled to have Ms. Kervitsky join us. I am confident that she will provide superior leadership for our patient
relations and research efforts."
- Read the Full Article Senator Patty Murray’s Floor Statement in Congress Introducing S. 3703, the PFREA
POSTED: Sunday, August 15, 2010
Mr. President, I am pleased to introduce the Pulmonary Fibrosis Research Enhancement Act. Even though pulmonary
fibrosis, or PF, kills almost as many people as breast cancer every year, it has not received the attention it
deserves.
Imagine being told by a doctor that you have a life-threatening disease with no known cure, no consistent standard
of care, and no reliable prognosis. Though environmental factors, including occupational exposure to pollutants,
are believed to play a role in its onset, PF has no strong demographic profile. In most cases, the doctor can’t
even tell you what has caused you to get sick. That is exactly the situation faced by the 48,000 people who are
diagnosed with PF every year in the United States.
Dr. Nancy Snyderman and NBC's Robert Bazell of NBC's TODAY Show diseases IPF in an interview with
California patient Bob O'Rourke, who suffers from the disease and will die from it unless he receives
a lung transplant in time.
Mike Blazer of Alabama and other patients need your support, get your shirt today. Watch
Mike's Interview
that aired on a local TV Station.
POSTED: Monday, February 1, 2010
The Coalition for Pulmonary Fibrosis, The Pulmonary Fibrosis Foundation and the Pulmonary Fibrosis
Association of Texas today announced the launch of a special, grassroots campaign to build increased
national awareness of Pulmonary Fibrosis (PF). "Blue Shirt Friday" is the first combined national
effort by the three nonprofit organizations that each focus on the fight for treatments and a cure
for the fatal lung disease that takes as many lives each year as breast cancer ...
The Pulmonary Fibrosis Association of Texas, Inc. conducted its 3rd annual golf tournament on November 9,
2009 at the Walden on Lake Houston Country Club. The tournament was a fun and successful event for the
organization. A special thanks goes out to all of our sponsors.
